Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.08%
#4 aPriori aPriori +187.76%
#5 Bedrock Bedrock +78.72%
#6 Cysic Cysic +52.73%
#7 Prom Prom +43.01%
#8 Playnance Playnance +34.94%
#9 Bitway Bitway +27.98%
#10 COTI COTI +25.34%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rank in Stocks #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Share Price
$0.0009
Last synced: 2025-05-27
Market Cap
$1.15K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Arch Therapeutics, Inc. (ARTH)

Category

Healthcare
Number of shares outstanding for Arch Therapeutics, Inc. (ARTH)
Number of shares outstanding as of June 2024: 4.44M
According to Arch Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 4.44M. At the end of September 2022 the company had 1.20M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Arch Therapeutics, Inc. (ARTH) from 2011 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 4.44M 44.57%
2023 3.07M 156.27%
2022 1.20M 9.05%
2021 1.10M 16.99%
2020 940.26K 13.05%
2019 831.70K 8.92%
2018 763.56K 7.00%
2017 713.61K 17.50%
2016 607.31K 49.23%
2015 406.97K 20.60%
2014 337.46K 105.18%
2013 164.48K 482.71%
2012 28.23K -52.21%
2011 59.07K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,612.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,299.20%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR